Prelude Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-47,247
| Closed | -$594K | – | 1335 |
|
|
2024
Q4 | $594K | Buy |
+47,247
| New | +$594K | 0.04% | 451 |
|
|
2024
Q1 | – | Sell |
-20,400
| Closed | -$611K | – | 1381 |
|
|
2023
Q4 | $611K | Buy |
+20,400
| New | +$611K | 0.04% | 365 |
|
|
2020
Q1 | – | Sell |
-184
| Closed | -$4K | – | 1440 |
|
|
2019
Q4 | $4K | Buy |
+184
| New | +$4K | ﹤0.01% | 1308 |
|
|
2019
Q3 | – | Sell |
-204
| Closed | -$3K | – | 1498 |
|
|
2019
Q2 | $3K | Buy |
204
+46
| +29% | +$676 | ﹤0.01% | 1151 |
|
|
2019
Q1 | $3K | Buy |
158
+3
| +2% | +$57 | ﹤0.01% | 1275 |
|
|
2018
Q4 | $2K | Buy |
+155
| New | +$2K | ﹤0.01% | 1315 |
|
|
2018
Q3 | – | Sell |
-8,133
| Closed | -$160K | – | 1622 |
|
|
2018
Q2 | $160K | Buy |
+8,133
| New | +$160K | 0.01% | 631 |
|